GLP1s dont usually cause hypoglycemia by themselves, but the risk rises when combined with insulin or sulfonylureas
In one of the most consequential healthcare deals of the year, President Trumps new drug-pricing pact with Eli Lilly and Novo Nordisk slashes the cost of blockbuster GLP-1 drugs like Wegovy and Zepbound, turning a luxury medicine into a mainstream benefitand forcing Ro, Hims, Mochi Health, and other telehealth players to rethink their most lucrative business model
AND Final approval of the version to be published
After 3 months of TRT, his energy started to return, along with his gains at the gym
Note that the Wegovy pill is distinct from oral semaglutide as Rybelsus , which uses the same GLP-1 mechanism but is licensed in the UK only for type 2 diabetes at lower doses (3 to 14 mg), not for weight management
Cost reduction A 5 mg vial of compounded semaglutide costs roughly $100 to $200 depending on the pharmacy